Inaugural Online Speaking Forum
A large part of SCORI is exposing students to the intricacies of cancer and the various careers that are present with the common goal of improving cancer care and eventually making cancer a thing of the past. This exposure is largely accomplished via a variety of speaking engagements allowing students to hear from distinguished speakers in the field of oncology whether an oncologist, a radiation therapist, or a cancer researcher.
To further our mission, we are pleased to announce our first online speaking engagement. This will feature Dr. Larissa Nekhlyudov, a renowned physician specialized in Cancer Survivorship practicing at Brigham & Women's Hospital and the Dana-Farber Cancer Institute. Dr. Nekhlyudov will be presenting based on questions posed by SCORI members. Dr. Nekhlyudov will be delivering a presentation based on inquiries submitted by SCORI members. To have your questions addressed by Dr. Nekhlyudov, we kindly invite you to complete the query form following your completion of the SCORI membership application by May 7th at 5:00 PM.
Biography
Dr. Larissa Nekhlyudov is a board-certified internal medicine physician practicing at Brigham & Women's Hospital in Boston, Massachusetts, a professor of Medicine at Harvard Medical School, and Clinical Director of Internal Medicine for Cancer Survivors at the Dana–Farber Cancer Institute. Dr. Nekhlyudov received her MD from the Mount Sinai School of Medicine in 1995 and completed her residency in internal medicine at the Yale-New Haven Hospital and the Yale Primary Care Residency Program. She then pursued a research fellowship focusing on cancer and received an MPH from the Harvard School of Public Health.
In addition to being a primary care provider, she has extensive research experience in the field of cancer survivorship. Her publications (including journal articles, book chapters, and two books), as well as her broad-ranging educational programs, have promoted awareness among healthcare professionals about the ongoing needs of cancer patients. She has a profound interest in improving the care of cancer survivors and the interconnections between primary and oncology care. She has led numerous efforts, including developing the Quality of Cancer Survivorship Care Framework, which outlines recommendations aiming to provide coordinated, comprehensive care for cancer survivors. Indulging in a multitude of endeavors, her commitment to cancer advocacy and patient education is commonly present.
Career Path and Trajectory
An internal medicine physician, also known as an internist, specializes in adult medicine and is trained to solve diagnostic problems, manage severe long-term illnesses, and help patients with complex chronic conditions. Internists most commonly see the big picture. Their deep training and knowledge of the entire human body and its organ systems give them a unique perspective of how everything works in unison. Internists spend time analyzing and establishing connections from multiple data sets in order to identify solutions for optimal health outcomes.
The career path to becoming an internist is long and rigorous. Four years of undergraduate study, obtaining a bachelor’s degree, four years of medical school, three to four years of internal medicine residency, and oftentimes a fellowship is needed in order to pursue a sub-specialty. A licensing exam is also required for practicing independently after residency. Passing the United States Medical Licensing Exam (USMLE) is crucial to becoming an internist. Some doctors continue to take the board exam in their state, which allows them to become board-certified. Obtaining board certification is an additional level of proof that a doctor is well-qualified, which helps instill trust in patients and encourage them to establish care.
Dr. Nekhlyudov will be speaking in regards to her unique career path in becoming a general internist specialized in the relatively new field of cancer survivorship. We encourage all SCORI members to take advantage of this exceptional opportunity to have their questions addressed by a leading expert in cancer survivorship. By participating in this event, we continue to advance our collective mission of making cancer a thing of the past and ensuring a brighter future for cancer patients and survivors alike.